JY
EDVA

Jeff Yass’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Jeff Yass’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,446
Closed -$32.5K – 13456
2025
Q3 		$32.5K Buy
+3,446
New +$30K ﹤0.01% 11964
2025
Q1 		– Sell
-542
Closed -$14K – 13330
2024
Q4 		$14K Sell
542
-290
-35% -$9.61K ﹤0.01% 11957
2024
Q3 		$33.5K Sell
832
-19
-2% -$957 ﹤0.01% 11507
2024
Q2 		$31.3K Sell
851
-18
-2% -$844 ﹤0.01% 11551
2024
Q1 		$64K Sell
869
-238
-21% -$19K ﹤0.01% 11453
2023
Q4 		$97.8K Sell
1,107
-696
-39% -$66.3K ﹤0.01% 11350
2023
Q3 		$170K Buy
1,803
+529
+42% +$68.5K ﹤0.01% 10409
2023
Q2 		$228K Buy
1,274
+885
+228% +$162K ﹤0.01% 10003
2023
Q1 		$102K Sell
389
-108
-22% -$21.4K ﹤0.01% 11278
2022
Q4 		$76.5K Buy
+497
New +$87.2K ﹤0.01% 11168
2022
Q2 		– Sell
-550
Closed -$199K – 13817
2022
Q1 		$250K Buy
+550
New +$281K ﹤0.01% 10722

Other funds holding EDVA

LWM
Lifetime Wealth Management Rockwall, Texas $171M AUM
CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Jeff Yass's EDVA Position: Q4 2025 in Review

Jeff Yass sold out of Endovia Health Sciences, Inc. (EDVA) in Q4 2025, closing a stake of 3,446 shares — an estimated $32.5K sold.

Jeff Yass first reported a position in EDVA in Q1 2022 and held it in 11 quarters. The position peaked at $250K in Q1 2022. 13 funds tracked by Wall St. Rank hold EDVA as of Q4 2025.

  • Jeff Yass reported no remaining Endovia Health Sciences, Inc. position as of Q4 2025 after selling out during the quarter.
  • Jeff Yass sold 3,446 Endovia Health Sciences, Inc. shares in Q4 2025, an estimated $32.5K.
  • Jeff Yass first reported a position in Endovia Health Sciences, Inc. in Q1 2022 and held it in 11 quarters.
  • Jeff Yass's Endovia Health Sciences, Inc. position peaked at $250K in Q1 2022.
  • 13 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.